Novel monoclonal antibodies recognizing the active conformation of epidermal growth factor receptor

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Precise regulation of epidermal growth factor receptor (EGFR) is vital for cellular growth control.
• Existing methods for detecting activated EGFR, primarily relying on phosphorylation, have limitations in specificity.
• There is a need for tools that can specifically identify the active conformation of EGFR.

Purpose of the Study:

• To establish novel monoclonal antibodies capable of recognizing activated EGFR independently of its phosphorylation state.
• To evaluate the utility of these antibodies in detecting active EGFR conformations in various cellular contexts.

Main Methods:

• Development of monoclonal antibodies targeting activated EGFR.
• Application of immunoprecipitation and immunofluorescence assays to detect EGFR.
• Analysis of EGFR conformation changes induced by ligand binding.
• Evaluation of antibody reactivity with constitutively active EGFR mutants.

Main Results:

• Successfully established monoclonal antibodies that detect activated EGFR independent of phosphorylation.
• Antibodies identified active EGFR states via immunoprecipitation and immunofluorescence.
• Antibodies recognize epitopes exposed upon ligand-induced conformational changes.
• Antibodies preferentially detected constitutively active EGFR mutants common in lung cancer.

Conclusions:

• The novel monoclonal antibodies are effective tools for detecting activated EGFR conformations.
• These antibodies offer a new approach for analyzing active EGFR in research and diagnostics.
• The tools may aid in understanding EGFR's role in diseases like lung cancer.